FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Geneviève Chêne

Research Profile

Disorders

Procedures

Living Beings

HIV-1
HIV-2

Chemicals & Drugs

Concepts & Ideas

Geographic Areas

France

Co-author Network

Publications

TOP 3
Jannie van der Helm; Geneviève Chêne; Julia Del Amo; Maria Dorrucci; Ronald B Geskus; Laurence Meyer; Roberto Muga; Kholoud Porter; Maria Prins; Caroline Sabin
Effect of HCV infection on cause-specific mortality after HIV seroconversion, before and after 1997.
Patrice Couzigou; Juliette Foucher; Vincent Leroy; Patrick Marcellin; Sophie Pérusat; Thierry Poynard; Pascale Trimoulet; Marc Bourlière; Jean-Pierre Bronowicki; Geneviève Chêne
Interferon-gamma with peginterferon alpha-2a and ribavirin in nonresponder patients with chronic hepatitis C (ANRS HC16 GAMMATRI).
Fabrice Bonnet; Mathias Bruyand; Gwenaelle Catheline; Geneviève Chêne; Francois Dabis; Jean-François Dartigues; Frédéric-Antoine Dauchy; Patrick Dehail; Carine Greib; Fabienne Marquant; Patrick Mercié; Philippe Morlat; Didier Neau; Laura Richert; Hélène Amieva; Charlotte Bernard
Cognitive disorders in HIV-infected patients: are they HIV-related?

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Geneviève Chêne (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Jannie van der Helm; Geneviève Chêne; Julia Del Amo; Maria Dorrucci; Ronald B Geskus; Laurence Meyer; Roberto Muga; Kholoud Porter; Maria Prins; Caroline Sabin
Effect of HCV infection on cause-specific mortality after HIV seroconversion, before and after 1997.
Gastroenterology 2013;144(4):751-760.e2.
2013: Patrice Couzigou; Juliette Foucher; Vincent Leroy; Patrick Marcellin; Sophie Pérusat; Thierry Poynard; Pascale Trimoulet; Marc Bourlière; Jean-Pierre Bronowicki; Geneviève Chêne
Interferon-gamma with peginterferon alpha-2a and ribavirin in nonresponder patients with chronic hepatitis C (ANRS HC16 GAMMATRI).
Journal of gastroenterology and hepatology 2013;28(2):329-34.
2013: Fabrice Bonnet; Mathias Bruyand; Gwenaelle Catheline; Geneviève Chêne; Francois Dabis; Jean-François Dartigues; Frédéric-Antoine Dauchy; Patrick Dehail; Carine Greib; Fabienne Marquant; Patrick Mercié; Philippe Morlat; Didier Neau; Laura Richert; Hélène Amieva; Charlotte Bernard
Cognitive disorders in HIV-infected patients: are they HIV-related?
AIDS (London, England) 2013;27(3):391-400.
2013: Benoit Visseaux; Antoine Bénard; Françoise Brun-Vézinet; Charlotte Charpentier; Geneviève Chêne; Florence Damond; Diane Descamps; Lucile Larrouy; Sophie Matheron; Audrey Taieb
Concordance between HIV-2 genotypic coreceptor tropism predictions based on plasma RNA and proviral DNA.
AIDS (London, England) 2013;27(2):292-5.
2013: Valérie Journot; Sophie Pérusat-Villetorte; Aminata Tall; Caroline Bouyssou; Geneviève Chêne; Sandrine Couffin-Cadiergues; Catherine Fagard
Preserving participant anonymity during remote preenrollment consent form checking.
Clinical trials (London, England) 2013;10(3):460-2.
2013: Valérie Journot; Sophie Pérusat-Villetorte; Aminata Tall; Caroline Bouyssou; Geneviève Chêne; Sandrine Couffin-Cadiergues
Remote preenrollment checking of consent forms to reduce nonconformity.
Clinical trials (London, England) 2013;10(3):449-59.
2013: Charlotte Charpentier; Geneviève Chêne; Céline Colin; Diane Descamps; Catherine Fagard; Christine Jacomet; Christine Katlama; Jean-Michel Molina; Anne-Marie Taburet; Benoit Visseaux; Yazdan Yazdanpanah; Françoise Brun-Vézinet
Role of baseline HIV-1 DNA level in highly-experienced patients receiving raltegravir, etravirine and darunavir/ritonavir regimen (ANRS139 TRIO trial).
PloS one 2013;8(1):e53621.
2012: Rodolphe Thiébaut; Romain Antoine; Françoise Brun-Vézinet; Jacqueline Capeau; Charlotte Charpentier; Geneviève Chêne; Gilles Collin; Florence Damond; Diane Descamps; Sophie Matheron; Audrey Taieb
Association of soluble CD14 and inflammatory biomarkers with HIV-2 disease progression.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2012;55(10):1417-25.
2012: M Maria Glymour; Christophe Tzourio; Geneviève Chêne; carole dufouil
Brain MRI markers and dropout in a longitudinal study of cognitive aging: the Three-City Dijon Study.
Neurology 2012;79(13):1340-8.
2012: Catherine Fagard; Christine Jacomet; Christine Katlama; Jean-Michel Molina; Agathe Rami; Daniel Vittecoq; Yazdan Yazdanpanah; Patrick Yeni; Charlotte Charpentier; Geneviève Chêne; Céline Colin; Diane Descamps
Long-term efficacy and safety of raltegravir, etravirine, and darunavir/ritonavir in treatment-experienced patients: week 96 results from the ANRS 139 TRIO trial.
Journal of acquired immune deficiency syndromes (1999) 2012;59(5):489-93.
2012: François Dabis; Antonella d'Arminio Monforte; Stéphane De Wit; Matthias Egger; Jade Ghosn; Jesper Grarup; Virginia Isern; Ole Kirk; Catherine Leport; Charlotte Lewden; Murielle Mary-Krause; Amanda Mocroft; Cristina Mussini; Niels Obel; George Panos; Santiago Perez-Hoyos; Caroline Sabin; Paz Sobrino-Vegas; Christoph Stephan; Ramón Teira; Carlo Torti; Ard van Sighem; Jan Christian Wasmuth; Andrea Antinori; Vincent Bouteloup; Alexandra Calmy; Antonella Castagna; Geneviève Chêne
All-cause mortality in treated HIV-infected adults with CD4 ≥500/mm3 compared with the general population: evidence from a large European observational cohort collaboration.
International journal of epidemiology 2012;41(2):433-45.
2012: Hassan Nazih; François Raffi; Jacques Reynes; Audrey Taïeb; Jean-Marie Bard; Jill-Patrick Cassuto; Geneviève Chêne; Patrick Choutet; Tristan Ferry; Catherine Leport
Peroxisome proliferator activating receptor alpha and gamma polymorphisms and metabolic abnormalities in HIV-infected patients receiving highly active antiretroviral therapy: the ANRS CO8 APROCO-COPILOTE study.
AIDS research and human retroviruses 2012;28(4):393-9.
2012: Yves Lévy; Jean-Michel Molina; Philippe Morlat; Béatrice Poirier; Christine Rouzioux; Daniel Sereni; Irini Sereti; Rodolphe Thiébaut; Alain Venet; Jean-Paul Viard; Laurence Weiss; Céline Boucherie; Geneviève Chêne; Jean-François Delfraissy; Pierre-Marie Girard; Marie-Lise Gougeon; Cliff Lane; Anne-Sophie Lascaux
Effect of intermittent interleukin-2 therapy on CD4+ T-cell counts following antiretroviral cessation in patients with HIV.
AIDS (London, England) 2012;26(6):711-20.
2012: Jacqueline Capeau; Geneviève Chêne; Vincent Guiyedi; Christine Katlama; Catherine Leport; Camelia Protopopescu; Francois Raffi; Dominique Salmon-Ceron; Jean-Philippe Bastard; Vincent Bouteloup
Ten-year diabetes incidence in 1046 HIV-infected patients started on a combination antiretroviral treatment.
AIDS (London, England) 2012;26(3):303-14.
2012: Marie Préau; Camelia Protopopescu; François Raffi; J M Ragnaud; D Rey; Bruno Spire; Geneviève Chêne; Catherine Leport; Fabienne Marcellin; C Perronne
Satisfaction with care in HIV-infected patients treated with long-term follow-up antiretroviral therapy: the role of social vulnerability.
AIDS care 2012;24(4):434-43.
2011: Michael J Mugavero; Javier Murillas; Sonia Napravnik; Andrew Phillips; Heather J Ribaudo; Sharon A Riddler; Michael S Saag; Colette Smith; Jonathan A C Sterne; Christoph Wyen; Sophie Abgrall; Juan Berenguer; Geneviève Chêne; Antonella d'Arminio Monforte; Frank de Wolf; Pere Domingo; M John Gill; Jodie L Guest; Roy M Gulick; Huldrych F Günthard; Ross Harris; Richard Haubrich; Robert Hogg; Mari M Kitahata; Margaret May
Comparative effectiveness of initial antiretroviral therapy regimens: ACTG 5095 and 5142 clinical trials relative to ART-CC cohort study.
Journal of acquired immune deficiency syndromes (1999) 2011;58(3):253-60.
2011: Mathias Bruyand; Geneviève Chêne; François Dabis; Stéphane Geffard; Estibaliz Lazaro; Olivier Leleux; Philippe Morlat; Didier Neau; Marie-Anne Vandenhende; Fabrice Bonnet
HIV-induced immune deficiency is associated with a higher risk of hepatocarcinoma, ANRS CO3 Aquitaine Cohort, France, 1998-2008.
Journal of hepatology 2011;55(5):1058-62.
2011: Julia Bohlius; Fabrice Bonnet; François Boué; Ana Maria Caro-Murillo; Geneviève Chêne; Gary Clifford; Matthias Egger; Gerd Fätkenheuer; Margaret May; Jose M Miro; Amanda Mocroft; Niels Obel; Vassilios Paparizos; Maria Prins; Kurt Schmidlin
HIV-1-related Hodgkin lymphoma in the era of combination antiretroviral therapy: incidence and evolution of CD4⁺ T-cell lymphocytes.
Blood 2011;117(23):6100-8.
2011: Jannie J van der Helm; Heiner C Bucher; Geneviève Chêne; Julia del Amo; Maria Dorrucci; Ronald B Geskus; John Gill; Osamah Hamouda; Kholoud Porter; Maria Prins; Mette Sannes
The hepatitis C epidemic among HIV-positive MSM: incidence estimates from 1990 to 2007.
AIDS (London, England) 2011;25(8):1083-91.
2011: Linda Wittkop; Andrea Antinori; Hannah Castro; Geneviève Chêne; Bonaventura Clotet; Céline Colin; Alessandro Cozzi-Lepri; Andrea de Luca; Frank de Wolf; David Dunn; Federico García; Huldrych F Günthard; Ali Judd; Jesper Kjaer; Claudia Kücherer; Jens D Lundgren; Bernard Masquelier; Niels Obel; Roger Paredes; Andrew Phillips; Deenan Pillay; Kholoud Porter; Anton Pozniak; Christoph Stephan; Rodolphe Thiébaut; Carlo Torti; Ard I van Sighem; Viktor von Wyl
Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study.
The Lancet infectious diseases 2011;11(5):363-71.
2011: Nathalie Aladjidi; Brigitte Bader-Meunier; André Baruchel; Yves Bertrand; Geneviève Chêne; Alain Fischer; Fanny Fouyssac; Virginie Gandemer; Julien Jeanpetit; Thierry Leblanc; Guy Leverger; Gérard Michel; Brigitte Nelken; Yves Perel; Marie Quitterie Picat; Alain Robert; Pierre Rohrlich; Hélène Savel; Jean Louis Stephan; Caroline Thomas
New insights into childhood autoimmune hemolytic anemia: a French national observational study of 265 children.
Haematologica 2011;96(5):655-63.
2011: Rodolphe Thiébaut; Sophie Matheron; Audrey Taieb; Francoise Brun-Vezinet; Geneviève Chêne; Brigitte Autran
Long-term nonprogressors and elite controllers in the ANRS CO5 HIV-2 cohort.
AIDS (London, England) 2011;25(6):865-7.
2011: Laura Richert; Patrick Dehail; Patrick Mercié; Frédéric-Antoine Dauchy; Mathias Bruyand; Carine Greib; François Dabis; Fabrice Bonnet; Geneviève Chêne
High frequency of poor locomotor performance in HIV-infected patients.
AIDS (London, England) 2011;25(6):797-805.
2011: Charlotte Charpentier; Bénédicte Roquebert; Olivier Delelis; Lucile Larrouy; Sophie Matheron; Roland Tubiana; Marina Karmochkine; Xavier Duval; Geneviève Chêne; Alexandre Storto; Gilles Collin; Antoine Bénard; Florence Damond; Jean-François Mouscadet; Françoise Brun-Vézinet; Diane Descamps
Hot spots of integrase genotypic changes leading to HIV-2 resistance to raltegravir.
Antimicrobial agents and chemotherapy 2011;55(3):1293-5.
2011: Charlotte Charpentier; Geneviève Chêne; Florence Damond; Olivier Delelis; Diane Descamps; Lucile Larrouy; Sophie Matheron; Jean-François Mouscadet; Françoise Brun-Vézinet; Pauline Campa
Long-lasting persistence of integrase resistance mutations in HIV-2-infected patients after raltegravir withdrawal.
Antiviral therapy 2011;16(6):937-40.
2011: Francis Leclerc; Astrid Botte; Geneviève Chêne; Stéphane Leteurtre
Adjunctive corticosteroid therapy in pediatric severe sepsis: many unsolved questions.
Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies 2011;12(1):101-2.
2011: Sébastien Gallien; Valérie Journot; Willy Rozenbaum; Patrick Yéni; Philippe Morlat; Isabelle Poizot-Martin; Jacques Reynes; Véronique Reliquet; Pascale Leclercq; François SIMON; Geneviève Chêne; Jean-Michel Molina
Four year follow-up of simplification therapy with once-daily emtricitabine, didanosine and efavirenz in HIV-infected patients (ALIZE ANRS 099 trial).
The Journal of antimicrobial chemotherapy 2011;66(1):184-91.
2011: Valérie Journot; Jean-Pierre Pignon; Claude Gaultier; Véronique Daurat; Annie Bouxin-Métro; Bruno Giraudeau; pierre-marie preux; Jean-Marc Tréluyer; Sylvie Chevret; Valérie Plättner; Claire Thalamas; Stéphanie Clisant; Philippe Ravaud; Geneviève Chêne
Validation of a risk-assessment scale and a risk-adapted monitoring plan for academic clinical research studies--the Pre-Optimon study.
Contemporary clinical trials 2011;32(1):16-24.
2010: Philippe Halfon; Sophie Pérusat; Marc Bourlière; Jean-Pierre Bronowicki; Pascale Trimoulet; Yves Benhamou; Vincent Leroy; Patrick Marcellin; Juliette Foucher; Guillaume Penaranda; Geneviève Chêne; Patrice Couzigou
Neutralizing antibodies to interferon-α and circulating interferon in patients with chronic hepatitis C non-responding to pegylated interferon plus ribavirin re-treated by pegylated interferon-α-2a and ribavirin (ANRS HC16 GAMMATRI substudy).
Journal of medical virology 2010;82(12):2027-31.
2010: Sara Lodi; Andrew Phillips; Giota Touloumi; Nikos Pantazis; Heiner C Bucher; Abdel Babiker; Geneviève Chêne; Philippe Vanhems; Kholoud Porter
CD4 decline in seroconverter and seroprevalent individuals in the precombination of antiretroviral therapy era.
AIDS (London, England) 2010;24(17):2697-704.
2010: Charlotte Charpentier; Lucile Larrouy; Gilles Collin; Florence Damond; sophie matheron; Geneviève Chêne; Ting Nie; Ray F Schinazi; Françoise Brun-Vézinet; Diane Descamps
In-vitro phenotypic susceptibility of HIV-2 clinical isolates to the integrase inhibitor S/GSK1349572.
AIDS (London, England) 2010;24(17):2753-5.
2010: Charlotte Charpentier; Bénédicte Roquebert; Céline Colin; Anne-Marie Taburet; Catherine Fagard; Christine Katlama; Jean-Michel Molina; Christine Jacomet; Françoise Brun-Vézinet; Geneviève Chêne; Yazdan Yazdanpanah; Diane Descamps
Resistance analyses in highly experienced patients failing raltegravir, etravirine and darunavir/ritonavir regimen.
AIDS (London, England) 2010;24(17):2651-6.
2010: Aurélie Barrail-Tran; Yazdan Yazdanpanah; Lauriane Goldwirt; Geneviève Chêne; Céline Colin; Christophe Piketty; Diane Bollens; Christine Katlama; Diane Descamps; Jean-Michel Molina; Catherine Fagard; Anne-Marie Taburet
Pharmacokinetics of etravirine, raltegravir and darunavir/ritonavir in treatment experienced patients.
AIDS (London, England) 2010;24(16):2581-3.
2010: Véronique Avettand-Fenoel; Vincent Bouteloup; Adeline Mélard; Catherine Fagard; Marie-Laure Chaix; Pascale Leclercq; Geneviève Chêne; Jean-Paul Viard; Christine Rouzioux
Higher HIV-1 DNA associated with lower gains in CD4 cell count among patients with advanced therapeutic failure receiving optimized treatment (ANRS 123--ETOILE).
The Journal of antimicrobial chemotherapy 2010;65(10):2212-4.
2010: Claire Rabian; Inga Tschöpe; Philippe Lesprit; Christine Katlama; Jean-Michel Molina; Jean-Luc Meynard; Jean-François Delfraissy; Geneviève Chêne; Yves Lévy
Cellular CD4 T cell responses to the diphtheria-derived carrier protein of conjugated pneumococcal vaccine and antibody response to pneumococcal vaccination in HIV-infected adults.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2010;50(8):1174-83.
2010: Camelia Protopopescu; Perrine Roux; Maria-Patrizia Carrieri; Christine Katlama; Fidéline Collin; Jean-Marc Besnier; Geneviève Chêne; Francois Raffi; Bruno Spire; Catherine Leport
Prolonged medically recorded treatment interruptions among HIV-infected patients on highly active antiretroviral therapy with controlled viremia: when physicians have to juggle patient negotiation and guidelines.
Journal of acquired immune deficiency syndromes (1999) 2010;53(4):544-6.
2010: Gaelle Encrenaz; Antoine Bénard; Virginie Rondeau; Fabrice Bonnet; Estibaliz Lazaro; Didier Neau; Michel Dupon; François Dabis; Patrick Mercié; Geneviève Chêne
Determinants of smoking cessation attempts among HIV-infected patients results from a hospital-based prospective cohort.
Current HIV research 2010;8(3):212-7.
2010: J-J Laurichesse; A Taieb; C Capoulade-Metay; Christine Katlama; V Villes; M-C Drobacheff-Thiebaud; François Raffi; Geneviève Chêne; I Theodorou; Catherine Leport
Is long-term virological response related to CCR5 Delta32 deletion in HIV-1-infected patients started on highly active antiretroviral therapy?
HIV medicine 2010;11(4):239-44.
2010: Marcel Wolbers; Abdel Babiker; Caroline Sabin; Jim Young; Maria Dorrucci; Geneviève Chêne; Cristina Mussini; Kholoud Porter; Heiner C Bucher
Pretreatment CD4 cell slope and progression to AIDS or death in HIV-infected patients initiating antiretroviral therapy--the CASCADE collaboration: a collaboration of 23 cohort studies.
PLoS medicine 2010;7(2):e1000239.
2010: Mojgan Hessamfar-Bonarek; Philippe Morlat; Dominique Salmon; Patrice Cacoub; thierry may; Fabrice Bonnet; Eric Rosenthal; Dominique Costagliola; Charlotte Lewden; Geneviève Chêne
Causes of death in HIV-infected women: persistent role of AIDS. The 'Mortalité 2000 & 2005' Surveys (ANRS EN19).
International journal of epidemiology 2010;39(1):135-46.
2010: Antoine Bénard; Patrick Mercié; Ahmadou Alioum; Fabrice Bonnet; Estibaliz Lazaro; Michel Dupon; Didier Neau; François Dabis; Geneviève Chêne
Bacterial pneumonia among HIV-infected patients: decreased risk after tobacco smoking cessation. ANRS CO3 Aquitaine Cohort, 2000-2007.
PloS one 2010;5(1):e8896.
2009: Catherine Leport; Vincent Bouteloup; Jérôme Rossert; Michel Garré; Laura Iordache; Pierre Dellamonica; Serge Herson; Francois Raffi; Geneviève Chêne
Long-term evolution and determinants of renal function in HIV-infected patients who began receiving combination antiretroviral therapy in 1997-1999, ANRS CO8 APROCO-COPILOTE.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009;49(12):1950-4.
2009: Bruno Clément; Geneviève Chêne; Françoise Degos
A national collection of liver tumours: lessons learnt from 6 years of biobanking in France.
Cancer letters 2009;286(1):140-4.
2009: Dominique Breilh; Sarah Djabarouti; Pascale Trimoulet; Brigitte Le Bail; Michel Dupon; Jean-Marie Ragnaud; Hervé Fleury; Marie-Claude Saux; Rodolphe Thiébaut; Geneviève Chêne; Didier Neau
Ribavirin plasma concentration predicts sustained virological response to peginterferon Alfa 2a plus ribavirin in previously treated HCV-HIV-coinfected patients.
Journal of acquired immune deficiency syndromes (1999) 2009;52(3):428-30.
2009: David M Moore; Ross Harris; Viviane Lima; Hogg Robert; Margaret May; Benita Yip; Amy Justice; Amanda Mocroft; Peter Reiss; Fiona Lampe; Geneviève Chêne; Dominique Costagliola; Luigia Elzi; Michael J Mugavero; Antonella d'Arminio Monforte; Caroline Sabin; Daniel Podzamczer; Gerd Fätkenheuer; Schlomo Staszewski; John Gill; Jonathan A C Sterne
Effect of baseline CD4 cell counts on the clinical significance of short-term immunologic response to antiretroviral therapy in individuals with virologic suppression.
Journal of acquired immune deficiency syndromes (1999) 2009;52(3):357-63.
2009: Emilie Lanoy; Margaret May; Amanda Mocroft; Andrew Phillip; Amy Justice; Geneviève Chêne; Hansjakob Furrer; Timothy Sterling; Antonella d'Arminio Monforte; Lluís Force; John Gill; Ross Harris; Hogg Robert; Jürgen Rockstroh; Mike Saag; Pavel Khaykin; Frank de Wolf; Jonathan A C Sterne; Dominique Costagliola
Prognosis of patients treated with cART from 36 months after initiation, according to current and previous CD4 cell count and plasma HIV-1 RNA measurements.
AIDS (London, England) 2009;23(16):2199-208.
2009: Mathias Bruyand; Rodolphe Thiébaut; Sylvie Lawson-Ayayi; Pierre Joly; Annie Jeanne Sasco; Patrick Mercié; Jean Luc Pellegrin; Didier Neau; François Dabis; Philippe Morlat; Geneviève Chêne; Fabrice Bonnet
Role of uncontrolled HIV RNA level and immunodeficiency in the occurrence of malignancy in HIV-infected patients during the combination antiretroviral therapy era: Agence Nationale de Recherche sur le Sida (ANRS) CO3 Aquitaine Cohort.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009;49(7):1109-16.
2009: Gaëlle Pédrono; Rodolphe Thiébaut; Ahmadou Alioum; Philippe Lesprit; Bernard Fritzell; Yves Lévy; Geneviève Chêne
A new endpoint definition improved clinical relevance and statistical power in a vaccine trial.
Journal of clinical epidemiology 2009;62(10):1054-61.
2009: Benoît Marin; Rodolphe Thiébaut; Heiner C Bucher; Virginie Rondeau; Dominique Costagliola; Maria Dorrucci; Osamah Hamouda; Maria Prins; Sarah Walker; Kholoud Porter; Caroline Sabin; Geneviève Chêne
Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy.
AIDS (London, England) 2009;23(13):1743-53.
2009: Tristan Ferry; François Raffi; Fidéline Collin-Filleul; Michel Dupon; Pierre Dellamonica; Anne Waldner; Christophe Strady; Geneviève Chêne; Catherine Leport; Vincent Le Moing
Uncontrolled viral replication as a risk factor for non-AIDS severe clinical events in HIV-infected patients on long-term antiretroviral therapy: APROCO/COPILOTE (ANRS CO8) cohort study.
Journal of acquired immune deficiency syndromes (1999) 2009;51(4):407-15.
2009: Jean-Paul Viard; Catherine Fagard; Marie-Laure Chaix; Christine Rouzioux; Vincent Bouteloup; Michelle Bentata; Nathalie Colin de Verdière; Golriz Pahlavan; Laurence Weiss; Yves Lévy; Geneviève Chêne
Immunological success is predicted by enfuvirtide but not interleukin-2 therapy in immunodepressed patients.
AIDS (London, England) 2009;23(11):1383-8.
2009: Patrick Peretti-Watel; Virginie Villes; Xavier Duval; Fidéline Collin; Jacques Reynes; Alain Sobel; Camelia Protopopescu; Geneviève Chêne; Bruno Spire; François Raffi
How do HIV-infected smokers react to cigarette price increases? Evidence from the APROCO-COPILOTE-ANRS CO8 Cohort.
Current HIV research 2009;7(4):462-7.
2009: Pierre-Marie Girard; André Cabié; Christian Michelet; Renaud Verdon; Christine Katlama; Patrick Mercié; Laurence Morand-Joubert; Pascal Pétour; Françoise Monchecourt; Geneviève Chêne; Aldo Trylesinski
A randomized trial of two-drug versus three-drug tenofovir-containing maintenance regimens in virologically controlled HIV-1 patients.
The Journal of antimicrobial chemotherapy 2009;64(1):126-34.
2009: Antoine Bénard; Florence Damond; Pauline Campa; Gilles Peytavin; Diane Descamps; Caroline Lascoux-Combes; Audrey Taieb; François SIMON; Brigitte Autran; Françoise Brun-Vézinet; Geneviève Chêne; sophie matheron
Good response to lopinavir/ritonavir-containing antiretroviral regimens in antiretroviral-naive HIV-2-infected patients.
AIDS (London, England) 2009;23(9):1171-3.
2009: Fidéline Collin; Xavier Duval; Vincent Le Moing; Lionel Piroth; Firas Al Kaied; Patrice Massip; Virginie Villes; Geneviève Chêne; François Raffi
Ten-year incidence and risk factors of bone fractures in a cohort of treated HIV1-infected adults.
AIDS (London, England) 2009;23(8):1021-4.
2009: Eric Rosenthal; D Salmon-Céron; Charlotte Lewden; V Bouteloup; G Pialoux; Fabrice Bonnet; M Karmochkine; thierry may; M François; Christine Burty; Eric Jougla; Dominique Costagliola; Philippe Morlat; Geneviève Chêne; Patrice Cacoub
Liver-related deaths in HIV-infected patients between 1995 and 2005 in the French GERMIVIC Joint Study Group Network (Mortavic 2005 study in collaboration with the Mortalité 2005 survey, ANRS EN19).
HIV medicine 2009;10(5):282-9.
2009: Yves Levy; Christine Lacabaratz; Laurence Weiss; Jean-Paul Viard; Cecile Goujard; Jean-Daniel Lelièvre; François Boué; Jean-Michel Molina; Christine Rouzioux; Véronique Avettand-Fénoêl; Thérèse Croughs; Stéphanie Beq; Rodolphe Thiébaut; Geneviève Chêne; Michel MORRE; Jean-François Delfraissy
Enhanced T cell recovery in HIV-1-infected adults through IL-7 treatment.
The Journal of clinical investigation 2009;119(4):997-1007.
2009: Dominique Salmon-Ceron; Eric Rosenthal; Charlotte Lewden; Vincent Bouteloup; thierry may; Christine Burty; Fabrice Bonnet; Dominique Costagliola; Eric Jougla; Caroline Semaille; Philippe Morlat; Patrice Cacoub; Geneviève Chêne
Emerging role of hepatocellular carcinoma among liver-related causes of deaths in HIV-infected patients: The French national Mortalité 2005 study.
Journal of hepatology 2009;50(4):736-45.
2009: Geneviève Chêne; Rodolphe Thiébaut
Options for clinical trials of pre and post-natal treatments for congenital toxoplasmosis.
Memórias do Instituto Oswaldo Cruz 2009;104(2):299-304.
2009: Fabrice Bonnet; Christine Burty; Charlotte Lewden; Dominique Costagliola; thierry may; Vincent Bouteloup; Eric Rosenthal; Eric Jougla; Patrice Cacoub; Dominique Salmon; Geneviève Chêne; Philippe Morlat
Changes in cancer mortality among HIV-infected patients: the Mortalité 2005 Survey.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009;48(5):633-9.
2008: Vincent Le Moing; A Taïeb; P Longuet; C Lewden; V Delcey; M C Thiebaut Drobacheff; Geneviève Chêne; Catherine Leport
Pregnancy may be followed by an inflexion of the immune reconstitution in HIV-infected women who receive antiretroviral drugs before conception.
HIV medicine 2008;9(10):897-900.
2008: Matthieu Lafaurie; Fidéline Collin; Michele Bentata; Michel Garré; Catherine Leport; Yves Levy; Cécile Goujard; Geneviève Chêne; Jean-Michel Molina
Switch from zidovudine- to non-zidovudine-containing regimens is associated with modest haematological improvement and no obvious clinical benefit: a substudy of the ANRS 099 ALIZE trial.
The Journal of antimicrobial chemotherapy 2008;62(5):1122-9.
2008: Charlotte Lewden; Geneviève Chêne; Philippe Morlat; François Raffi; François Dabis; Catherine Leport
[Mortality rate of HIV-infected adults compared with the general population: long-term and CD4-lymphocyte-dependent results].
Médecine sciences : M/S 2008;24(10):804-6.
2008: Bénédicte Roquebert; Laurent Blum; Gilles Collin; Florence Damond; Gilles Peytavin; Juliette Leleu; sophie matheron; Geneviève Chêne; Françoise Brun-Vézinet; Diane Descamps
Selection of the Q148R integrase inhibitor resistance mutation in a failing raltegravir containing regimen.
AIDS (London, England) 2008;22(15):2045-6.
2008: Charlotte Lewden; thierry may; Eric Rosenthal; Christine Burty; Fabrice Bonnet; Dominique Costagliola; Eric Jougla; Caroline Semaille; Philippe Morlat; Dominique Salmon; Patrice Cacoub; Geneviève Chêne
Changes in causes of death among adults infected by HIV between 2000 and 2005: The "Mortalité 2000 and 2005" surveys (ANRS EN19 and Mortavic).
Journal of acquired immune deficiency syndromes (1999) 2008;48(5):590-8.
2008: Marie Gueudin; Antoine Bénard; Geneviève Chêne; sophie matheron; François Simon
Significant differences in DNA viral load between HIV-1 and HIV-2 infected patients.
AIDS (London, England) 2008;22(12):1519-20.
2008: Didier Neau; Pascale Trimoulet; Edwige Pereira; Marie-Edith Lafon; Anne Gervais; Jean-Marie Ragnaud; Michel Dupon; Jean-Luc Ecobichon; Geneviève Chêne; François Raffi
Evolution of plasma hepatitis C virus load in patients coinfected by HIV and hepatitis C Virus started on a protease inhibitor-containing antiretroviral regimen, Agence Nationale de Recherches sur le SIDA CO8 APROCO-COPILOTE cohort.
Journal of acquired immune deficiency syndromes (1999) 2008;48(2):227-9.
2008: L Rachid Salmi; Samy Suissa; Geneviève Chêne; Roger Salamon
Clinically informative measures of the effect of drugs or other interventions.
British journal of clinical pharmacology 2008;65(6):935-41.
2008: Gilles Pialoux; Hakim Hocini; Sophie Pérusat; Benjamin Silberman; Dominique Salmon-Ceron; Laurence Slama; Valérie Journot; Emmanuelle Mathieu; Christophe Gaillard; Karine Petitprez; Odile Launay; Geneviève Chêne
Phase I study of a candidate vaccine based on recombinant HIV-1 gp160 (MN/LAI) administered by the mucosal route to HIV-seronegative volunteers: the ANRS VAC14 study.
Vaccine 2008;26(21):2657-66.
2008: Laura Richert; Vincent Bouteloup; Rodolphe Thiébaut; Geneviève Chêne
Methodological issues of non-inferiority trials in HIV-infected patients: a need for consensus?
AIDS (London, England) 2008;22(8):996-7.
2008: Aurélie Barrail-Tran; Laurence Morand-Joubert; Gwendoline Poizat; Gilles Raguin; Clotilde Le Tiec; François Clavel; Elisabeth DAM; Geneviève Chêne; Pierre-Marie Girard; Anne-Marie Taburet
Predictive values of the human immunodeficiency virus phenotype and genotype and of amprenavir and lopinavir inhibitory quotients in heavily pretreated patients on a ritonavir-boosted dual-protease-inhibitor regimen.
Antimicrobial agents and chemotherapy 2008;52(5):1642-6.
2008: Delphine Desbois; Bénédicte Roquebert; Gilles Peytavin; Florence Damond; Gilles Collin; Antoine Bénard; Pauline Campa; Sophie Matheron; Geneviève Chêne; Françoise Brun-Vézinet; Diane Descamps
In vitro phenotypic susceptibility of human immunodeficiency virus type 2 clinical isolates to protease inhibitors.
Antimicrobial agents and chemotherapy 2008;52(4):1545-8.
2008: Julia Drylewicz; Sophie Matheron; Estibaliz Lazaro; Florence Damond; Fabrice Bonnet; François Simon; François Dabis; Françoise Brun Vezinet; Geneviève Chêne; Rodolphe Thiébaut
Comparison of viro-immunological marker changes between HIV-1 and HIV-2-infected patients in France.
AIDS (London, England) 2008;22(4):457-68.
2008: Erica L Gollub; Valériane Leroy; Ruth Gilbert; Geneviève Chêne; Martine Wallon
Effectiveness of health education on Toxoplasma-related knowledge, behaviour, and risk of seroconversion in pregnancy.
European journal of obstetrics, gynecology, and reproductive biology 2008;136(2):137-45.
2008: François Raffi; Charlotte Lewden; Geneviève Chêne
Is nevirapine-based therapy discontinuation in hepatitis C co-infected patients a more important mortality determinant than hypersensitivity.
AIDS (London, England) 2008;22(3):435-6.
2008: Marie Gueudin; Florence Damond; Joséphine Braun; Audrey Taïeb; Véronique Lemée; Jean-Christophe Plantier; Geneviève Chêne; Sophie Matheron; Françoise Brun-Vézinet; François SIMON
Differences in proviral DNA load between HIV-1- and HIV-2-infected patients.
AIDS (London, England) 2008;22(2):211-5.
2008: Ross J Harris; Jonathan A C Sterne; Sophie Abgrall; François Dabis; Peter Reiss; Michael Saag; Andrew N Phillips; Geneviève Chêne; John M Gill; Amy C Justice; Jürgen Rockstroh; Caroline A Sabin; Amanda Mocroft; Heiner C Bucher; Hogg Robert; Antonella d'Arminio Monforte; Margaret May; Matthias Egger
Prognostic importance of anaemia in HIV type-1-infected patients starting antiretroviral therapy: collaborative analysis of prospective cohort studies.
Antiviral therapy 2008;13(8):959-67.
2007: Philippe Lesprit; Gaëlle Pédrono; Jean-Michel Molina; Cécile Goujard; Pierre-Marie Girard; Nathalie Sarrazin; Christine Katlama; Patrick Yéni; Pascale Morineau; Jean-François Delfraissy; Geneviève Chêne; Yves Lévy
Immunological efficacy of a prime-boost pneumococcal vaccination in HIV-infected adults.
AIDS (London, England) 2007;21(18):2425-34.
2007: Fabrice Bonnet; Geneviève Chêne; Rodolphe Thiébaut; Michel Dupon; Sylvie Lawson-Ayayi; Jean-Luc Pellegrin; François Dabis; Philippe Morlat
Trends and determinants of severe morbidity in HIV-infected patients: the ANRS CO3 Aquitaine Cohort, 2000-2004.
HIV medicine 2007;8(8):547-54.
2007: Frédéric-Antoine Dauchy; Didier Gruson; Geneviève Chêne; J Viot; Christiane Bebear; Jeanne Maugein; M C Bézian; Hervé Dutronc; Michel Dupon
Prognostic factors in adult community-acquired bacterial meningitis: a 4-year retrospective study.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2007;26(10):743-6.
2007: Camelia Protopopescu; Fabienne Marcellin; Bruno Spire; Marie Préau; Renaud Verdon; Dominique Peyramond; François Raffi; Geneviève Chêne; Catherine Leport; Maria Patrizia Carrieri
Health-related quality of life in HIV-1-infected patients on HAART: a five-years longitudinal analysis accounting for dropout in the APROCO-COPILOTE cohort (ANRS CO-8).
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2007;16(4):577-91.
2007: Vincent Le Moing; Rodolphe Thiébaut; Geneviève Chêne; A Sobel; Patrice Massip; F Collin; Marie-Caroline Meyohas; F Al Kaïed; Catherine Leport; François Raffi
Long-term evolution of CD4 count in patients with a plasma HIV RNA persistently <500 copies/mL during treatment with antiretroviral drugs.
HIV medicine 2007;8(3):156-63.
2007: Fidéline Collin; Geneviève Chêne; Sylvie Retout; Gilles Peytavin; Dominique Salmon; Elisabeth Bouvet; François Raffi; Rodolphe Garraffo; France Mentré; Xavier Duval
Indinavir trough concentration as a determinant of early nephrolithiasis in HIV-1-infected adults.
Therapeutic drug monitoring 2007;29(2):164-70.
2007: C Brunet-François; Audrey Taieb; Bernard Masquelier; Vincent Le Moing; Charlotte Lewden; Pierre Dellamonica; Lise Cuzin; Clotilde Allavena; B Spire; Geneviève Chêne; François Raffi
[Lopinavir/ritonavir in HIV-infected patient with long-term virological failure: immunovirological response and tolerance in 121 patients of the ANRS CO8 Aproco-Copilote cohort].
Médecine et maladies infectieuses 2007;37(3):172-7.
2007: Rodolphe Thiébaut; Sandy Leproust; Geneviève Chêne; Ruth Gilbert
Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients' data.
Lancet 2007;369(9556):115-22.
2007: Gilles Raguin; Gwendoline Poizat; Laurence Morand-Joubert; Anne-Marie Taburet; Clotilde Le Tiec; François Clavel; Geneviève Chêne; Pierre-Marie Girard
Salvage therapy with amprenavir, lopinavir and ritonavir is durably potent in HIV-infected patients in virological failure: 1-year results.
AIDS (London, England) 2007;21(2):241-3.
2007: Virginie Villes; Bruno Spire; Charlotte Lewden; Christian Perronne; Jean-Marc Besnier; Michel Garré; Geneviève Chêne; Catherine Leport; Maria Patrizia Carrieri; Vincent Le Moings
The effect of depressive symptoms at ART initiation on HIV clinical progression and mortality: implications in clinical practice.
Antiviral therapy 2007;12(7):1067-74.
2007: Jean-Michel Molina; Valérie Journot; André Furco; Pierre Palmer; Nathalie de Castro; François Raffi; Philippe Morlat; thierry may; Corinne Rancinan; Geneviève Chêne
Five-year follow up of once-daily therapy with emtricitabine, didanosine and efavirenz (Montana ANRS 091 trial).
Antiviral therapy 2007;12(3):417-22.
2007: Fabrice Bonnet; Valérie Aurillac-Lavignolle; Dominique Breilh; Rodolphe Thiébaut; Evelyne Peuchant; Noëlle Bernard; Denis Lacoste; François Dabis; Jacques Beylot; Geneviève Chêne; Philippe Morlat
Pravastatin in HIV-infected patients treated with protease inhibitors: a placebo-controlled randomized study.
HIV clinical trials 2007;8(1):53-60.
2007: Michael Fayon; Nawar Tayara; Christine Germain; Marie-Luce Choukroun; Eric Dumas De La Roque; Geneviève Chêne; Dominique Breilh; Roger Marthan; Jean-Louis Demarquez
Efficacy and tolerance of high-dose inhaled ipratropium bromide vs. terbutaline in intubated premature human neonates.
Neonatology 2007;91(3):167-73.
2007: Geneviève Chêne; Bahia Amellal; Gaëlle Pédrono; Karine Gourlain; Corinne Rancinan; Valérie Journot; Laurent Cotte; Pierre Palmer; Nathalie De Castro; Vincent Calvez; Jean-Michel Molina
Changes in the peripheral blood mtDNA levels in naive patients treated by different nucleoside reverse transcriptase inhibitor combinations and their association with subsequent lipodystrophy.
AIDS research and human retroviruses 2007;23(1):54-61.
2007: Geneviève Chêne
Epidemiological and clinical usefulness of HIV/AIDS cohort studies: towards a global collaboration.
Enfermedades infecciosas y microbiología clínica 2007;25(1):3-4.
2006: Charlotte Lewden; Eric Jougla; A Alioum; Gérard Pavillon; L Lièvre; Philippe Morlat; Dominique Salmon; thierry may; Geneviève Chêne; Dominique Costagliola
Number of deaths among HIV-infected adults in France in 2000, three-source capture-recapture estimation.
Epidemiology and infection 2006;134(6):1345-52.
2006: Olivier Lortholary; Gwendoline Poizat; Valérie Zeller; Ségolène Neuville; André Boibieux; Muriel Alvarez; Pierre Dellamonica; Françoise Botterel; Françoise Dromer; Geneviève Chêne
Long-term outcome of AIDS-associated cryptococcosis in the era of combination antiretroviral therapy.
AIDS (London, England) 2006;20(17):2183-91.
2006: Alain Makinson; Bernard Masquelier; Audrey Taieb; Gilles Peytavin; Anne Waldner-Combernoux; Gilles Collin; Geneviève Chêne; Françoise Brun-Vézinet; François Raffi; Vincent Le Moing; Catherine Leport; Diane Descamps
Presence of numerous stop codons in HIV-1 reverse transcriptase proviral DNA sequences from patients with virological response to HAART.
AIDS (London, England) 2006;20(9):1327-9.
2006: Vincent Le Moing; C Rabaud; Valérie Journot; Xavier Duval; Lise Cuzin; Jill-Patrice Cassuto; F Al Kaied; Pierre Dellamonica; Geneviève Chêne; François Raffi
Incidence and risk factors of bacterial pneumonia requiring hospitalization in HIV-infected patients started on a protease inhibitor-containing regimen.
HIV medicine 2006;7(4):261-7.
2006: Sophie Capdepont; Valérie Aurillac-Lavignolle; Muriel Faure; Michel Dupon; Philippe Morlat; Jean-Marie Ragnaud; Geneviève Chêne; Hervé Fleury; Bernard Masquelier
An additive/subtractive genotypic score as a determinant of the virological response to didanosine in HIV-1 infected patients.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2006;36(1):36-42.
2006: Diane Descamps; Florence Damond; Antoine Bénard; Sophie Matheron; Pauline Campa; Audrey Taieb; Réda Yahyaoui; Geneviève Chêne; Françoise Brun-Vézinet
No association between GB virus C infection and disease progression in HIV-2-infected patients from the French ANRS HIV-2 cohort.
AIDS (London, England) 2006;20(7):1076-9.
2006: Maria Patrizia Carrieri; Catherine Leport; Camelia Protopopescu; Jill-Patrice Cassuto; Elisabeth Bouvet; Dominique Peyramond; François Raffi; Jean-Paul Moatti; Geneviève Chêne; Bruno Spire
Factors associated with nonadherence to highly active antiretroviral therapy: a 5-year follow-up analysis with correction for the bias induced by missing data in the treatment maintenance phase.
Journal of acquired immune deficiency syndromes (1999) 2006;41(4):477-85.
2006: A Bénard; Jean-François Tessier; J Rambeloarisoa; F Bonnet; H Fossoux; Didier Neau; Hervé Dutronc; Estibaliz Lazaro; François Dabis; Geneviève Chêne
HIV infection and tobacco smoking behaviour: prospects for prevention? ANRS CO3 Aquitaine Cohort, 2002.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2006;10(4):378-83.
2006: Rodolphe Thiébaut; Jérémie Guedj; Hélène Jacqmin-Gadda; Geneviève Chêne; Pascale Trimoulet; Didier Neau; Daniel Commenges
Estimation of dynamical model parameters taking into account undetectable marker values.
BMC medical research methodology 2006;6():38.
2006: Laurence Morand-Joubert; Charlotte Charpentier; Gwendoline Poizat; Geneviève Chêne; Elisabeth DAM; Gilles Raguin; Anne-Marie Taburet; Pierre-Marie Girard; Allan J Hance; François Clavel
Low genetic barrier to large increases in HIV-1 cross-resistance to protease inhibitors during salvage therapy.
Antiviral therapy 2006;11(2):143-54.
2006: Rodolphe Thiébaut; Hélène Jacqmin-Gadda; S Walker; C Sabin; M Prins; J Del Amo; K Porter; François Dabis; Geneviève Chêne
Determinants of response to first HAART regimen in antiretroviral-naïve patients with an estimated time since HIV seroconversion.
HIV medicine 2006;7(1):1-9.
2006: Rodolphe Thiébaut; Valériane Leroy; Ahmadou Alioum; Christine Binquet; Gwendoline Poizat; L Rachid Salmi; Luuk Gras; Roger Salamon; Ruth Gilbert; Geneviève Chêne
Biases in observational studies of the effect of prenatal treatment for congenital toxoplasmosis.
European journal of obstetrics, gynecology, and reproductive biology 2006;124(1):3-9.
2005: Isabelle Pellegrin; Rodolphe Thiébaut; Patrick Blanco; Jean-François Viallard; Marie-Hélène Schrive; Patrick Merel; Geneviève Chêne; Hervé Fleury; Jean-François Moreau; Jean-Luc Pellegrin
Can highly active antiretroviral therapy be interrupted in patients with sustained moderate HIV RNA and > 400 CD4+ cells/microl? Impact on immunovirological parameters.
Journal of medical virology 2005;77(2):164-72.
2005: Florence Damond; Gilles Collin; Diane Descamps; Sophie Matheron; Sophie Pueyo; Audrey Taieb; Pauline Campa; Antoine Benard; Geneviève Chêne; Françoise Brun Vezinet
Improved sensitivity of human immunodeficiency virus type 2 subtype B plasma viral load assay.
Journal of clinical microbiology 2005;43(8):4234-6.
2005: Vincent Le Moing; Geneviève Chêne; Bruno Spire; François Raffi; Catherine Leport
[Outcome of HIV-infected patients after 5 years of antiretroviral therapy including a protease inhibitor: the Aproco/Copilote Cohort].
Presse médicale (Paris, France : 1983) 2005;34(10 Suppl):1S31-7.
2005: R Thiébaut; C Lewden; Geneviève Chêne
[Epidemiology of discordant virologic and immunologic responses in HIV-1 infected patients].
Médecine et maladies infectieuses 2005;35 Suppl 2():S31-2.
2005: thierry may; Dominique Salmon; F Bonnet; P Cacoub; Charlotte Lewden; Geneviève Chêne
[<< Mortalité 2005 >> study in collaboration with Mortavic].
Médecine et maladies infectieuses 2005;35 Suppl 2():S28-30.
2005: Dominique Salmon-Ceron; Charlotte Lewden; Philippe Morlat; Sibylle Bévilacqua; Eric Jougla; Fabrice Bonnet; Laurence Héripret; Dominique Costagliola; thierry may; Geneviève Chêne
Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol.
Journal of hepatology 2005;42(6):799-805.
2005: Bernard Masquelier; Edwige Pereira; Gilles Peytavin; Diane Descamps; Jacques Reynes; Renaud Verdon; Hervé Fleury; R Garraffo; Geneviève Chêne; François Raffi; Françoise Brun-Vézinet
Intermittent viremia during first-line, protease inhibitors-containing therapy: significance and relationship with drug resistance.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2005;33(1):75-8.
2005: Alphonse Kpozèhouen; Ahmadou Alioum; Xavier Anglaret; Philippe Van de Perre; Geneviève Chêne; Roger Salamon
Use of a Bayesian approach to decide when to stop a therapeutic trial: the case of a chemoprophylaxis trial in human immunodeficiency virus infection.
American journal of epidemiology 2005;161(6):595-603.
2005: Jacques Demotes-Mainard; Geneviève Chêne; Christian Libersa; Jean-Pierre Pignon
Clinical research infrastructures and networks in France: report on the French ECRIN workshop.
Thérapie 2005;60(2):183-99.
2005: Philippe Chauveau; Hiep Nguyen; Christian Combe; Geneviève Chêne; Raymond Azar; Noël J M Cano; Bernard Canaud; Denis Fouque; Martine Laville; Xavier Leverve; Hubert Roth; Michel Aparicio
Dialyzer membrane permeability and survival in hemodialysis patients.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2005;45(3):565-71.
2005: Xavier Duval; France Mentré; Claire Lamotte; Geneviève Chêne; Bruno Spire; Pierre Dellamonica; Xavière Panhard; Dominique Salmon; François Raffi; Gilles Peytavin; Catherine Leport
Indinavir plasma concentration and adherence score are codeterminant of early virologic response in HIV-infected patients of the APROCO cohort.
Therapeutic drug monitoring 2005;27(1):63-70.
2005: Charlotte Lewden; Dominique Salmon; Philippe Morlat; Sibylle Bévilacqua; Eric Jougla; Fabrice Bonnet; Laurence Héripret; Dominique Costagliola; thierry may; Geneviève Chêne
Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS.
International journal of epidemiology 2005;34(1):121-30.
2005: Rodolphe Thiébaut; Isabelle Pellegrin; Geneviève Chêne; Jean-François Viallard; Hervé Fleury; Jean-François Moreau; Jean-Luc Pellegrin; Patrick Blanco
Immunological markers after long-term treatment interruption in chronically HIV-1 infected patients with CD4 cell count above 400 x 10(6) cells/l.
AIDS (London, England) 2005;19(1):53-61.
2005: Florence Damond; Gilles Collin; Sophie Matheron; Gilles Peytavin; Pauline Campa; Séverine Delarue; Audrey Taieb; Antoine Bénard; Geneviève Chêne; Françoise Brun-Vézinet; Diane Descamps
Letter. In vitro phenotypic susceptibility to nucleoside reverse transcriptase inhibitors of HIV-2 isolates with the Q151M mutation in the reverse transcriptase gene.
Antiviral therapy 2005;10(7):861-5.
2005: Fabrice Bonnet; Charlotte Lewden; thierry may; Laurence Heripret; Eric Jougla; Sibylle Bevilacqua; Dominique Costagliola; Dominique Salmon; Geneviève Chêne; Philippe Morlat
Opportunistic infections as causes of death in HIV-infected patients in the HAART era in France.
Scandinavian journal of infectious diseases 2005;37(6-7):482-7.
2004: thierry may; Charlotte Lewden; F Bonnet; Laurence Heripret; Sibylle Bevilacqua; Eric Jougla; Dominique Costagliola; Philippe Morlat; Dominique Salmon; Geneviève Chêne
[Causes and characteristics of death among HIV-1 infected patients with immunovirologic response to antiretroviral treatment].
Presse médicale (Paris, France : 1983) 2004;33(21):1487-92.
2004: Diane Descamps; Florence Damond; Sophie Matheron; Gilles Collin; Pauline Campa; Séverine Delarue; Sophie Pueyo; Geneviève Chêne; Françoise Brun-Vézinet
High frequency of selection of K65R and Q151M mutations in HIV-2 infected patients receiving nucleoside reverse transcriptase inhibitors containing regimen.
Journal of medical virology 2004;74(2):197-201.
2004: Florence Damond; Sophie Matheron; Gilles Peytavin; Pauline Campa; Audrey Taieb; Gilles Collin; Christophe Delaunay; Geneviève Chêne; Françoise Brun-Vézinet; Diane Descamps
Selection of K65R mutation in HIV-2-infected patients receiving tenofovir-containing regimen.
Antiviral therapy 2004;9(4):635-6.
2004: Gilles Raguin; Geneviève Chêne; Laurence Morand-Joubert; Anne-Marie Taburet; Cécile Droz; Clotilde Le Tiec; François Clavel; Pierre-Marie Girard
Salvage therapy with amprenavir, lopinavir and ritonavir 200 mg/d or 400 mg/d in HIV-infected patients in virological failure.
Antiviral therapy 2004;9(4):615-25.
2004: Xavier Duval; Valérie Journot; Catherine Leport; Geneviève Chêne; Michel Dupon; Lise Cuzin; thierry may; Philippe Morlat; Anne Waldner; Roger Salamon; François Raffi
Incidence of and risk factors for adverse drug reactions in a prospective cohort of HIV-infected adults initiating protease inhibitor-containing therapy.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;39(2):248-55.
2004: Fabrice Bonnet; Charlotte Lewden; thierry may; Laurence Heripret; Eric Jougla; Sibylle Bevilacqua; Dominique Costagliola; Dominique Salmon; Geneviève Chêne; Philippe Morlat
Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy.
Cancer 2004;101(2):317-24.
2004: Charlotte Lewden; Milko Sobesky; André Cabié; Pierre Couppié; F Boulard; François Bissuel; thierry may; Philippe Morlat; Geneviève Chêne; Isabelle Lamaury; Dominique Salmon
[Causes of death among HIV infected adults in French Guyana and the French West Indies in the era of highly active antiretroviral therapy (HAART)].
Médecine et maladies infectieuses 2004;34(7):286-92.
2004: Charlotte Lewden; Hélène Jacqmin-Gadda; Jean-Louis Vildé; François Bricaire; Anne Waldner-Combernoux; thierry may; Lise Cuzin; Jean-Marie Lang; Catherine Leport; Geneviève Chêne
An example of nonrandom missing data for hepatitis C virus status in a prognostic study among HIV-infected patients.
HIV clinical trials 2004;5(4):224-31.
2004: Maria Winnock; Dominique Salmon-Céron; François Dabis; Geneviève Chêne
Interaction between HIV-1 and HCV infections: towards a new entity?
The Journal of antimicrobial chemotherapy 2004;53(6):936-46.
2004: Gwenola Gourvellec; Xavier Anglaret; Siaka Touré; Charlotte Huët; Nicole Dakoury-Dogbo; S Lafont; Thérèse N'Dri-Yoman; Geneviève Chêne; Roger Salamon
[Compliance in HIV infected adults. Study of opportunistic infection prophylaxis with cotrimoxazole in Ivory Coast].
Presse médicale (Paris, France : 1983) 2004;33(9 Pt 1):595-600.
2004: Anne-Marie Taburet; Gilles Raguin; Clotilde Le Tiec; Cécile Droz; Aurélie Barrail; Isabelle Vincent; Laurence Morand-Joubert; Geneviève Chêne; François Clavel; Pierre-Marie Girard
Interactions between amprenavir and the lopinavir-ritonavir combination in heavily pretreated patients infected with human immunodeficiency virus.
Clinical pharmacology and therapeutics 2004;75(4):310-23.
2004: Xavier Anglaret; Siaka Toure; Gwenola Gourvellec; Amah Tchehy; Lambert Zio; Marcel Zaho; Marie-Cécile Kassi; Jean Lehou; Hélène Coulibaly; Catherine Seyler; Thérèse N'Dri-Yoman; Roger Salamon; Geneviève Chêne
Impact of vital status investigation procedures on estimates of survival in cohorts of HIV-infected patients from Sub-Saharan Africa.
Journal of acquired immune deficiency syndromes (1999) 2004;35(3):320-3.
2004: Yazdan Yazdanpanah; Daouda Sissoko; Matthias Egger; Yves Mouton; Marcel Zwahlen; Geneviève Chêne
Clinical efficacy of antiretroviral combination therapy based on protease inhibitors or non-nucleoside analogue reverse transcriptase inhibitors: indirect comparison of controlled trials.
BMJ (Clinical research ed.) 2004;328(7434):249.
2003: Vincent Le Moing; Gilles Peytavin; Valérie Journot; Jacqueline Cottalorda; Elizabeth Bouvet; Geneviève Chêne; Marie Préau; Corinne Merle De Boever; Catherine Leport; François Raffi
Plasma levels of indinavir and nelfinavir at time of virologic response may have a different impact on the risk of further virologic failure in HIV-infected patients.
Journal of acquired immune deficiency syndromes (1999) 2003;34(5):497-9.
2003: Sophie Matheron; Sophie Pueyo; Florence Damond; François SIMON; Annie Leprêtre; Pauline Campa; Roger Salamon; Geneviève Chêne; Françoise Brun Vezinet
Factors associated with clinical progression in HIV-2 infected-patients: the French ANRS cohort.
AIDS (London, England) 2003;17(18):2593-601.
2003: Charles Balabaud; Maria Winnock; Geneviève Chêne; Françoise Degos
[Biological collection of primary liver tumors: a treasure of genes].
Gastroentérologie clinique et biologique 2003;27(12):1076-8.
2003: Maria Patrizia Carrieri; François Raffi; Charlotte Lewden; Alain Sobel; Christian Michelet; Valérie Cailleton; Geneviève Chêne; Catherine Leport; Jean-Paul Moatti; Bruno Spire
Impact of early versus late adherence to highly active antiretroviral therapy on immuno-virological response: a 3-year follow-up study.
Antiviral therapy 2003;8(6):585-94.
2003: Rodolphe Thiébaut; Hélène Jacqmin-Gadda; Valérie Journot; Françoise Ferchal; Corinne Rancinan; Jean-Michel Molina; Geneviève Chêne
Analysis of undetectable HIV RNA using survival analysis: results must be interpreted carefully.
HIV clinical trials 2003;4(6):417-20.
2003: Bernard Masquelier; Cecile Droz; Martin Dary; Christian Perronne; Virginie Ferré; Bruno Spire; Diane Descamps; François Raffi; Françoise Brun-Vézinet; Geneviève Chêne
R57K polymorphism in the human immunodeficiency virus type 1 protease as predictor of early virological failure in a cohort of antiretroviral-naive patients treated mostly with a nelfinavir-containing regimen.
Antimicrobial agents and chemotherapy 2003;47(11):3623-6.
2003: Geneviève Chêne
Efforts from observational cohorts to transpose results into useful recommendations for clinical management of HIV-infected patients.
AIDS (London, England) 2003;17(15):2259-60.
2003: Rodolphe Thiébaut; Marianne Savès; Patrick Mercié; Claire Cipriano; Geneviève Chêne; François Dabis
[Epidemiology of atherosclerotic cardiovascular risk in HIV-1 infected patients].
Presse médicale (Paris, France : 1983) 2003;32(30):1419-26.
2003: Geneviève Chêne; Jonathan A C Sterne; Margaret May; Dominique Costagliola; bruno ledergerber; Andrew N Phillips; François Dabis; J Lundgren; Antonella d'Arminio Monforte; F de Wolf; Hogg Robert; Peter Reiss; Amy Justice; Catherine Leport; Schlomo Staszewski; John Gill; G Fatkenheuer; Matthias Egger
Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studies.
Lancet 2003;362(9385):679-86.
2003: Marianne Savès; Geneviève Chêne; Pierre Ducimetière; Catherine Leport; Gwenaël Le Moal; Philippe Amouyel; Dominique Arveiler; Jean-Bernard Ruidavets; Jacques Reynes; Annie Bingham; François Raffi
Risk factors for coronary heart disease in patients treated for human immunodeficiency virus infection compared with the general population.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003;37(2):292-8.
2003: Rodolphe Thiébaut; Geneviève Chêne; Hélène Jacqmin-Gadda; Philippe Morlat; Patrick Mercié; Michel Dupon; Didier Neau; Hanta Ramaroson; François Dabis; Roger Salamon
Time-updated CD4+ T lymphocyte count and HIV RNA as major markers of disease progression in naive HIV-1-infected patients treated with a highly active antiretroviral therapy: the Aquitaine cohort, 1996-2001.
Journal of acquired immune deficiency syndromes (1999) 2003;33(3):380-6.
2003: Didier Neau; Pascale Trimoulet; Maria Winnock; Anne Rullier; Brigitte Le Bail; Denis Lacoste; Jean-Marie Ragnaud; Paulette Bioulac-Sage; Marie-Edith Lafon; Geneviève Chêne; Michel Dupon
Comparison of 2 regimens that include interferon-alpha-2a plus ribavirin for treatment of chronic hepatitis C in human immunodeficiency virus-coinfected patients.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003;36(12):1564-71.
2003: Dominique Salmon-Céron; Régis Lassalle; Alain Pruvost; Henri BENECH; Magali Bouvier-Alias; Christopher Payan; Cécile Goujard; Eric Bonnet; Fabien Zoulim; Philippe Morlat; Philippe Sogni; Sophie Pérusat; Jean-Marc Tréluyer; Geneviève Chêne
Interferon-ribavirin in association with stavudine has no impact on plasma human immunodeficiency virus (HIV) type 1 level in patients coinfected with HIV and hepatitis C virus: a CORIST-ANRS HC1 trial.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003;36(10):1295-304.
2003: Rodolphe Thiébaut; Hélène Jacqmin-Gadda; Catherine Leport; Christine Katlama; Dominique Costagliola; Vincent Le Moing; Philippe Morlat; Geneviève Chêne
Bivariate longitudinal model for the analysis of the evolution of HIV RNA and CD4 cell count in HIV infection taking into account left censoring of HIV RNA measures.
Journal of biopharmaceutical statistics 2003;13(2):271-82.
2003: Vincent Sibaud; Marie Beylot-Barry; Rodolphe Thiébaut; Marie Parrens; Béatrice Vergier; Michèle Delaunay; Claire Beylot; Geneviève Chêne; Jacky Ferrer; Antoine de Mascarel; Pierre Dubus; Jean-Philippe Merlio
Bone marrow histopathologic and molecular staging in epidermotropic T-cell lymphomas.
American journal of clinical pathology 2003;119(3):414-23.
2003: Patrizia Carrieri; Bruno Spire; Ségolène Duran; Christine Katlama; Dominique Peyramond; Cécile François; Geneviève Chêne; Jean-Marie Lang; Jean-Paul Moatti; Catherine Leport
Health-related quality of life after 1 year of highly active antiretroviral therapy.
Journal of acquired immune deficiency syndromes (1999) 2003;32(1):38-47.
2002: Bernard Masquelier; Gilles Peytavin; Catherine Leport; Cecile Droz; Ségolène Duran; Renaud Verdon; Jean-Marc Besnier; Geneviève Chêne; François Raffi; Françoise Brun-Vézinet
Mechanisms of early virologic failure in antiretroviral-naive patients starting protease inhibitor-containing regimens: the APROVIR Study.
The Journal of infectious diseases 2002;186(10):1503-7.
2002: Charlotte Lewden; Fabrice Bonnet; Sibylle Bevilacqua; Laurence Heripret; thierry may; Philippe Morlat; Eric Jougla; François Dabis; Geneviève Chêne; Dominique Salmon
[Causes of death in HIV-infected French drug users, 1995-2000].
Annales de médecine interne 2002;153(7 Suppl):2S4-10.
2002: Rodolphe Thiébaut; Hélène Jacqmin-Gadda; Geneviève Chêne; Catherine Leport; Daniel Commenges
Bivariate linear mixed models using SAS proc MIXED.
Computer methods and programs in biomedicine 2002;69(3):249-56.
2002: Charlotte Lewden; François Raffi; Lise Cuzin; Valérie Cailleton; Jean-Louis Vildé; Geneviève Chêne; Clotilde Allavena; Roger Salamon; Catherine Leport
Factors associated with mortality in human immunodeficiency virus type 1-infected adults initiating protease inhibitor-containing therapy: role of education level and of early transaminase level elevation (APROCO-ANRS EP11 study). The Antiprotéases Cohorte Agence Nationale de Recherches sur le SIDA EP 11 study.
The Journal of infectious diseases 2002;186(5):710-4.
2002: Hélène Jacqmin-Gadda; Pierre Joly; Daniel Commenges; Christine Binquet; Geneviève Chêne
Penalized likelihood approach to estimate a smooth mean curve on longitudinal data.
Statistics in medicine 2002;21(16):2391-402.
2002: Matthias Egger; Margaret May; Geneviève Chêne; Andrew N Phillips; bruno ledergerber; François Dabis; Dominique Costagliola; Antonella d'Arminio Monforte; Frank de Wolf; Peter Reiss; Jens D Lundgren; Amy C Justice; Schlomo Staszewski; Catherine Leport; Hogg Robert; Caroline A Sabin; M John Gill; Bernd Salzberger; Jonathan A C Sterne
Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies.
Lancet 2002;360(9327):119-29.
2002: Corinne Rancinan; Didier Neau; Marianne Savès; Sylvie Lawson-Ayayi; Fabrice Bonnet; Patrick Mercié; Michel Dupon; Patrice Couzigou; François Dabis; Geneviève Chêne
Is hepatitis C virus co-infection associated with survival in HIV-infected patients treated by combination antiretroviral therapy?
AIDS (London, England) 2002;16(10):1357-62.
2002: Victor de Lédinghen; Pascale Trimoulet; Maria Winnock; Pierre-Henri Bernard; Marc Bourlière; Isabelle Portal; André-Jean Rémy; Nathalie Szostak; Stéphane Lévy; Albert Tran; Armand Abergel; Geneviève Chêne; Hervé Fleury; Patrice Couzigou
Daily or three times per week interferon alpha-2b in combination with ribavirin or interferon alone for the treatment of patients with chronic hepatitis C not responding to previous interferon alone.
Journal of hepatology 2002;36(6):819-26.
2002: Pascale Trimoulet; Philippe Halfon; Eric Pohier; Hacène Khiri; Geneviève Chêne; Hervé Fleury
Evaluation of the VERSANT HCV RNA 3.0 assay for quantification of hepatitis C virus RNA in serum.
Journal of clinical microbiology 2002;40(6):2031-6.
2002: Pascale Trimoulet; Didier Neau; Brigitte Le Bail; Anne Rullier; Maria Winnock; Tatiana Galperine; Elisabeth Legrand; Evelyne Schvoerer; Michel Dupon; Jean-Marie Ragnaud; Paulette Bioulac-Sage; Geneviève Chêne; Hervé Fleury; Marie-Edith Lafon
Intrahepatic HCV RNA loads in 37 HIV-HCV co-infected patients with controlled HIV infection.
Journal of medical virology 2002;67(2):143-51.
2002: Marianne Savès; François Raffi; Jacqueline Capeau; Willy Rozenbaum; Jean-Marie Ragnaud; Christian Perronne; Arnaud Basdevant; Catherine Leport; Geneviève Chêne
Factors related to lipodystrophy and metabolic alterations in patients with human immunodeficiency virus infection receiving highly active antiretroviral therapy.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002;34(10):1396-405.
2002: Victor de Lédinghen; Pascale Trimoulet; Maria Winnock; Juliette Foucher; Marc Bourlière; Hervé Desmorat; Valérie Canva; Dominique Capron; Stéphane Lévy; François Mion; Paul-Régis Mannant; Geneviève Chêne; Hervé Fleury; Patrice Couzigou; Pierre-Henri Bernard
Daily or three times a week interferon alfa-2b in combination with ribavirin or interferon alone for the treatment of patients with chronic hepatitis C.
Journal of hepatology 2002;36(5):672-80.
2002: Karine Pérès; Muriel Rainfray; N Perrié; Jean-Paul Emeriau; Geneviève Chêne; Pascale Barberger-Gateau
[Incidence, risk factors and adequation of early readmission among the elderly].
Revue d'épidémiologie et de santé publique 2002;50(2):109-19.
2002: Fabrice Bonnet; Marianne Savès; Philippe Morlat; C Droz; Geneviève Chêne; Evelyne Peuchant; Noëlle Bernard; Denis Lacoste; Roger Salamon; Jacques Beylot
Correlations of soluble interleukin-2 and tumor necrosis factor type II receptors with immunologic and virologic responses under HAART.
Journal of clinical immunology 2002;22(2):75-82.
2002: Geneviève Chêne; Emmanuelle Angelini; Laurent Cotte; Jean-Marie Lang; Philippe Morlat; Corinne Rancinan; thierry may; Valérie Journot; François Raffi; Bernard Jarrousse; Michèle Grappin; Gérard Lepeu; Jean-Michel Molina
Role of long-term nucleoside-analogue therapy in lipodystrophy and metabolic disorders in human immunodeficiency virus-infected patients.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002;34(5):649-57.
2002: Vincent Le Moing; Rodolphe Thiébaut; Geneviève Chêne; Catherine Leport; Valérie Cailleton; Christian Michelet; Hervé Fleury; Serge Herson; François Raffi
Predictors of long-term increase in CD4(+) cell counts in human immunodeficiency virus-infected patients receiving a protease inhibitor-containing antiretroviral regimen.
The Journal of infectious diseases 2002;185(4):471-80.
2002: Vincent Le Moing; Geneviève Chêne; Catherine Leport; Charlotte Lewden; Ségolène Duran; Michel Garré; Bernard Masquelier; Michel Dupon; François Raffi
Impact of discontinuation of initial protease inhibitor therapy on further virological response in a cohort of human immunodeficiency virus-infected patients.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002;34(2):239-47.
2002: Vincent Le Moing; Geneviève Chêne; Maria Patrizia Carrieri; Ahmadou Alioum; Françoise Brun-Vézinet; Lionel Piroth; Jill-Patrice Cassuto; Jean-Paul Moatti; François Raffi; Catherine Leport
Predictors of virological rebound in HIV-1-infected patients initiating a protease inhibitor-containing regimen.
AIDS (London, England) 2002;16(1):21-9.
2001: A Attia; Charlotte Huët; Xavier Anglaret; Siaka Toure; Timothée Ouassa; Gwenola Gourvellec; Hervé Menan; Nicole Dakoury-Dogbo; Patrice Combe; Geneviève Chêne; Thérèse N'Dri-Yoman; Roger Salamon
HIV-1-related morbidity in adults, Abidjan, Côte d'Ivoire: a nidus for bacterial diseases.
Journal of acquired immune deficiency syndromes (1999) 2001;28(5):478-86.
2001: Valérie Journot; Geneviève Chêne; P Joly; Marianne Savès; Hélène Jacqmin-Gadda; Jean-Michel Molina; Roger Salamon
Viral load as a primary outcome in human immunodeficiency virus trials: a review of statistical analysis methods.
Controlled clinical trials 2001;22(6):639-58.
2001: Bernard Masquelier; Didier Neau; Geneviève Chêne; J Larbère; V Birac; Jean-Marie Ragnaud; Hervé J Fleury
Mechanism of virologic failure after substitution of a protease inhibitor by nevirapine in patients with suppressed plasma HIV-1 RNA.
Journal of acquired immune deficiency syndromes (1999) 2001;28(4):309-12.
2001: Nicole Dakoury-Dogbo; Xavier Anglaret; Timothée Ouassa; Siaka Toure; Dominique Bonard; Gwenola Gourvellec; Eugène Messou; Hervé Menan; Geneviève Chêne; Patrice Combe; François Dabis; Roger Salamon; Thérèse N'Dri-Yoman
[Causes of fever in adults infected by HIV-1. Ambulatory follow-up in the ANRS 059 trial in Abidjan, Ivory Coast].
Presse médicale (Paris, France : 1983) 2001;30(34):1674-80.
2001: V Picard; E Angelini; Anne Maillard; Ester Race; François Clavel; Geneviève Chêne; Françoise Ferchal; Jean-Michel Molina
Comparison of genotypic and phenotypic resistance patterns of human immunodeficiency virus type 1 isolates from patients treated with stavudine and didanosine or zidovudine and lamivudine.
The Journal of infectious diseases 2001;184(6):781-4.
2001: Yazdan Yazdanpanah; Geneviève Chêne; E Losina; S J Goldie; L D Merchadou; Serge Alfandari; G R Seage; L Sullivan; Catherine Marimoutou; A David Paltiel; Roger Salamon; Yves Mouton; K A Freedberg
Incidence of primary opportunistic infections in two human immunodeficiency virus-infected French clinical cohorts.
International journal of epidemiology 2001;30(4):864-71.
2001: Vincent Le Moing; Geneviève Chêne; Maria Patrizia Carrieri; Jean-Marc Besnier; Bernard Masquelier; R Salamon; C Bazin; J P Moatti; François Raffi; Catherine Leport
Clinical, biologic, and behavioral predictors of early immunologic and virologic response in HIV-infected patients initiating protease inhibitors.
Journal of acquired immune deficiency syndromes (1999) 2001;27(4):372-6.
2001: K Castetbon; Xavier Anglaret; Siaka Touré; Geneviève Chêne; Timothée Ouassa; A Attia; Thérèse N'Dri-Yoman; Denis Malvy; Roger Salamon; François Dabis
Prognostic value of cross-sectional anthropometric indices on short-term risk of mortality in human immunodeficiency virus-infected adults in Abidjan, Côte d'Ivoire.
American journal of epidemiology 2001;154(1):75-84.
2001: Catherine Marimoutou; Geneviève Chêne; Patrick Mercié; Didier Neau; S Farbos; Philippe Morlat; J Ceccaldi; François Dabis
Prognostic factors of combined viral load and CD4+ cell count responses under triple antiretroviral therapy, Aquitaine cohort, 1996-1998.
Journal of acquired immune deficiency syndromes (1999) 2001;27(2):161-7.
2001: Marianne Savès; Philippe Morlat; Geneviève Chêne; Evelyne Peuchant; Isabelle Pellegrin; Fabrice Bonnet; Noëlle Bernard; Denis Lacoste; Roger Salamon; Jacques Beylot
Prognostic value of plasma markers of immune activation in patients with advanced HIV disease treated by combination antiretroviral therapy.
Clinical immunology (Orlando, Fla.) 2001;99(3):347-52.
2001: Fabrice Bonnet; Marianne Savès; C Droz; Evelyne Peuchant; Geneviève Chêne; Jacques Beylot; Philippe Morlat
Increase of lipid plasma concentrations under protease inhibitor-containing regimens are not related to modifications of the tumour necrosis factor system.
AIDS (London, England) 2001;15(7):940-1.
2001: Charlotte Lewden; François Raffi; Geneviève Chêne; A Sobel; Catherine Leport
Mortality in a cohort of HIV-infected adults started on a protease inhibitor-containing therapy: standardization to the general population.
Journal of acquired immune deficiency syndromes (1999) 2001;26(5):480-2.
2001: Christine Binquet; Geneviève Chêne; Hélène Jacqmin-Gadda; Valérie Journot; Marianne Savès; Denis Lacoste; François Dabis
Modeling changes in CD4-positive T-lymphocyte counts after the start of highly active antiretroviral therapy and the relation with risk of opportunistic infections: the Aquitaine Cohort, 1996-1997.
American journal of epidemiology 2001;153(4):386-93.
2000: M Savès; François Raffi; P Clevenbergh; B Marchou; Anne Waldner-Combernoux; P Morlat; Vincent Le Moing; C Rivière; Geneviève Chêne; Catherine Leport
Hepatitis B or hepatitis C virus infection is a risk factor for severe hepatic cytolysis after initiation of a protease inhibitor-containing antiretroviral regimen in human immunodeficiency virus-infected patients. The APROCO Study Group.
Antimicrobial agents and chemotherapy 2000;44(12):3451-5.
2000: F Bonnet; Marianne Savès; C Droz; Evelyne Peuchant; Geneviève Chêne; Jacques Beylot; Philippe Morlat
Increase of atherogenic plasma profile in HIV-infected patients treated with protease inhibitor-containing regimens.
Journal of acquired immune deficiency syndromes (1999) 2000;25(2):199-200.
2000: Jean-Michel Molina; Françoise Ferchal; Corinne Rancinan; François Raffi; Willy Rozenbaum; Daniel Sereni; Philippe Morlat; Valérie Journot; JM Decazes; Geneviève Chêne
Once-daily combination therapy with emtricitabine, didanosine, and efavirenz in human immunodeficiency virus-infected patients.
The Journal of infectious diseases 2000;182(2):599-602.
2000: Pascale Trimoulet; Victor de Lédinghen; Didier K Ekouevi; Pierre-Henri Bernard; Patrick Merel; Geneviève Chêne; Patrice Couzigou; Hervé Fleury
TT virus infection during chronic hepatitis C.
The American journal of gastroenterology 2000;95(7):1765-9.
2000: Geneviève Chêne
[In a clinical trial, method is not sufficient, the purpose must be relevant].
La Revue du praticien 2000;50(8):851-5.
2000: F Saillourglénisson; Geneviève Chêne; L Rachid Salmi; Richard Hafner; Roger Salamon
[Effect of dapsone on survival in HIV infected patients: a meta- analysis of finished trials].
Revue d'épidémiologie et de santé publique 2000;48(1):17-30.
1999: Geneviève Chêne
[the epidemiology of HIV infection].
La Revue du praticien 1999;49(16):1732-7.
1999: Jean-Michel Molina; Geneviève Chêne; Françoise Ferchal; Valérie Journot; I Pellegrin; MN Sombardier; Corinne Rancinan; Laurent Cotte; Isabelle Madelaine; T Debord; JM Decazes
The ALBI trial: a randomized controlled trial comparing stavudine plus didanosine with zidovudine plus lamivudine and a regimen alternating both combinations in previously untreated patients infected with human immunodeficiency virus.
The Journal of infectious diseases 1999;180(2):351-8.
1999: Marianne Savès; Philippe Morlat; Geneviève Chêne; B Dumon; Evelyne Peuchant
Sex differences in HIV-1 viral load and TNF-alpha plasmatic level?
AIDS (London, England) 1999;13(11):1414-5.
1999: Xavier Anglaret; Geneviève Chêne; A Attia; Siaka Toure; S Lafont; Patrice Combe; K Manlan; Thérèse N'Dri-Yoman; Roger Salamon
Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Côte d'Ivoire: a randomised trial. Cotrimo-CI Study Group.
Lancet 1999;353(9163):1463-8.
1999: Noëlle Bernard; R Spira; S Ybanez; Geneviève Chêne; Philippe Morlat; Denis Lacoste; I Loury-Larivière; C Nouts; B Burucoa; M Lebras; Jacques Beylot
Prevalence and underestimation of pain in HIV-infected patients by physicians: a cross-sectional study in a day care hospital.
AIDS (London, England) 1999;13(2):293-5.
1998: Geneviève Chêne; Christine Binquet; Jean-François Moreau; Didier Neau; Isabelle Pellegrin; Denis Malvy; J Ceccaldi; Denis Lacoste; François Dabis
Changes in CD4+ cell count and the risk of opportunistic infection or death after highly active antiretroviral treatment. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine.
AIDS (London, England) 1998;12(17):2313-20.
1998: Michel Dupon; Catherine Marimoutou; Cécile Cazorla; Christine Binquet; Geneviève Chêne; Jean-Luc Pellegrin; Hervé Dutronc; C Nouts; François Dabis
Incidence of acquired immunodeficiency syndrome (AIDS)-related Kaposi's sarcoma in the Aquitaine Cohort, France, 1988-1996. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine.
International journal of epidemiology 1998;27(6):1078-82.
1998: Corinne Rancinan; Philippe Morlat; Geneviève Chêne; Stephane Guez; A Baquey; Jacques Beylot; Roger Salamon
IgE serum level: a prognostic marker for AIDS in HIV-infected adults?
The Journal of allergy and clinical immunology 1998;102(2):329-30.
1998: Geneviève Chêne; Philippe Morlat; Catherine Leport; Richard Hafner; L Dequae; Isabelle Charreau; Jean-Pierre Aboulker; Benjamin J Luft; J Aubertin; Jean-Louis Vildé; Roger Salamon
Intention-to-treat vs. on-treatment analyses of clinical trial data: experience from a study of pyrimethamine in the primary prophylaxis of toxoplasmosis in HIV-infected patients. ANRS 005/ACTG 154 Trial Group.
Controlled clinical trials 1998;19(3):233-48.
1998: Catherine Marimoutou; Geneviève Chêne; Isabelle Pellegrin; Jean-François Moreau; R Spira; Didier Neau; Denis Lacoste; J Ceccaldi; Denis Malvy; François Dabis
CD4+ lymphocyte count and plasma HIV RNA levels in a survey of 1602 HIV-infected patients in Bordeaux, France, 1996-1997. Groupe d'Epidemiologie Clinique da SIDA en Aquitaine.
AIDS (London, England) 1998;12(8):962-4.
1998: P Morlat; Geneviève Chêne; E Vimard; B Dumas; Jean-Marie Ragnaud; J Beylot
The presence of cotton-wool spots is predictive for the development of CMV retinitis.
International journal of STD & AIDS 1998;9(2):122-3.
1997: Michel Dupon; Bernard Masquelier; Cécile Cazorla; Geneviève Chêne; B Dumon; Jean-Marie Ragnaud; Bertille De Barbeyrac; C Bébéar; Jean-Yves Lacut; Hervé J Fleury
Acquired immunodeficiency syndrome-associated Kaposi's sarcoma and human herpesvirus 8 DNA detection in serial peripheral blood mononuclear cell samples.
Research in virology 1997;148(6):417-25.
1997: C d'Ivernois; Geneviève Chêne; Michel Dupon; F Dabis; Jean-Yves Lacut
[Is prognosis in AIDS patients different in cases of cardiac involvement? Prospective study of 34 patients].
Presse médicale (Paris, France : 1983) 1997;26(15):714.
1997: Catherine Marimoutou; Geneviève Chêne; François Dabis; Denis Lacoste; Roger Salamon
[Human immunodeficiency virus infection and AIDS in Aquitaine. 10 years' experience of a hospital information system, 1985-1995. Le Groupe d'Epidemiologie Clinique du SIDA en Aquitaine (GECSA)].
Presse médicale (Paris, France : 1983) 1997;26(15):703-10.
1997: Sophie Pueyo; L Rachid Salmi; Geneviève Chêne; Catherine Leport; Philippe Morlat; L Dequae; V Grégoire; Richard Hafner; Jean-Louis Vildé; Benjamin J Luft; J Aubertin; Roger Salamon
Survival after AIDS-defining events in patients with < 200 lymphocytes CD4+ x 10(6)/L who are toxoplasmosis antibody positive. ANRS 005/ACTG 154 Trial Group.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1997;14(5):459-64.
1997: Corinne Rancinan; Philippe Morlat; Geneviève Chêne; F Saillour; Stephane Guez; Denis Lacoste; Noëlle Bernard; M S Doutre; Claire Sériès; J Aubertin; Jacques Beylot; Roger Salamon
[Prevalence of clinical manifestations of allergic reactions in HIV infection. Cross sectional study of 115 subjects].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 1997;18(9):691-4.
1996: Francis Derouin; Catherine Leport; Sophie Pueyo; Philippe Morlat; B Letrillart; Geneviève Chêne; J L Ecobichon; Benjamin J Luft; J Aubertin; Richard Hafner; Jean-Louis Vildé; Roger Salamon
Predictive value of Toxoplasma gondii antibody titres on the occurrence of toxoplasmic encephalitis in HIV-infected patients. ANRS 005/ACTG 154 Trial Group.
AIDS (London, England) 1996;10(13):1521-7.
1996: Catherine Leport; Geneviève Chêne; Philippe Morlat; Benjamin J Luft; F Rousseau; Sophie Pueyo; Richard Hafner; J Miro; J Aubertin; Roger Salamon; Jean-Louis Vildé
Pyrimethamine for primary prophylaxis of toxoplasmic encephalitis in patients with human immunodeficiency virus infection: a double-blind, randomized trial. ANRS 005-ACTG 154 Group Members. Agence Nationale de Recherche sur le SIDA. AIDS Clinical Trial Group.
The Journal of infectious diseases 1996;173(1):91-7.
1995: Philippe Morlat; J B Hubert; Geneviève Chêne; M Buisson; M C Paty; Catherine Lasseur; Joël Constans; Noëlle Bernard; Jacques Beylot
[Effect of primary prevention of Pneumocystis carinii pneumonia on the inaugural clinical and biological presentation of AIDS: 624 cases (Aquitaine Cohort, 1985-1994)].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 1995;16(11):815-7.
1995: I Baldi; Sylvie Lawson-Ayayi; P Perez; Geneviève Chêne; M F Leconte des Floris; M Vicariot; M Vignal; G Palmer; L Rachid Salmi
[Fresh frozen plasma: a pilot study of the context of utilization and the indications].
Transfusion clinique et biologique : journal de la Société française de transfusion sanguine 1995;2(3):159-66.
1992: Philippe Morlat; P Parneix; D Douard; Denis Lacoste; Michel Dupon; Geneviève Chêne; Jean-Luc Pellegrin; Jean-Marie Ragnaud; François Dabis
Women and HIV infection: a cohort study of 483 HIV-infected women in Bordeaux, France, 1985-1991. The Groupe d'Epidémiologie Clinique du SIDA en Aquitaine.
AIDS (London, England) 1992;6(10):1187-93.